Intellectual Property Cases filed in Delaware
Cases 41 - 50 of 92
RSS Feed | View as table | Sort by last update
Ferring Pharmaceuticals Inc. et al v. Par Pharmaceutical Inc. We have downloadable decisions or orders for this case
as 1:2015cv00173
Plaintiff: Ferring Pharmaceuticals Inc. and Ferring International Center SA
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: Ferring International Center SA and Ferring Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Cosmo Technologies Limited et al v. Par Pharmaceutical Inc.
as 1:2015cv00116
Plaintiff: Cosmo Technologies Limited and Santarus Inc.
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: Cosmo Technologies Limited and Santarus Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc.
as 1:2015cv00078
Plaintiff: Novartis Pharmaceuticals Corporation and Novartis AG
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: Novartis AG and Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Tris Pharma Inc. v. Par Pharmaceutical Inc. et al
as 1:2015cv00068
Plaintiff: Tris Pharma Inc.
Defendant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_claimant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_defendant: Tris Pharma Inc.
Cause Of Action: 35 U.S.C. § 271
Reckitt Benckiser Pharmaceuticals Inc. et al v. Par Pharmaceutical Inc. et al
as 1:2014cv01573
Plaintiff: Reckitt Benckiser Pharmaceuticals Inc. and MonoSol Rx LLC
Defendant: Par Pharmaceutical Inc. and IntelGenX Technologies Corp.
Counter_claimant: IntelGenX Technologies Corp. and Par Pharmaceutical Inc.
Counter_defendant: MonoSol Rx LLC and Reckitt Benckiser Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc. We have downloadable decisions or orders for this case
as 1:2014cv01494
Plaintiff: Novartis Pharmaceuticals Corporation and Novartis AG
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: Novartis AG and Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Endo Phamaceuticals Inc. et al
as 1:2014cv01385
Plaintiff: Endo Phamaceuticals Inc. and Mallinckrodt LLC
Defendant: Par Pharmaceutical Companies Inc. and Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc. We have downloadable decisions or orders for this case
as 1:2014cv01289
Plaintiff: Novartis Pharmaceuticals Corporation and Novartis AG
Defendant: Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories, LLC et al v. Lupin Limited et al
as 1:2014cv01058
Plaintiff: Forest Laboratories, LLC , Forest Laboratories Holdings Ltd. and Adamas Pharmaceuticals Inc.
Defendant: Lupin Limited , Lupin Pharmaceuticals Inc. , Par Pharmaceutical Inc. and others
Counter_claimant: Lupin Pharmaceuticals Inc. , Lupin Limited , Anchen Pharmaceuticals Inc. and others
Counter_defendant: Adamas Pharmaceuticals Inc. , Forest Laboratories Holdings Ltd. and Forest Laboratories, LLC
Cause Of Action: 35 U.S.C. § 271
Prometheus Laboratories Inc. v. Par Pharmaceutical Companies Inc. et al
as 1:2014cv01017
Plaintiff: Prometheus Laboratories Inc.
Defendant: Par Pharmaceutical Companies Inc. and Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?